• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VENA SEAL CLOSURE SYSTEM; AGENT, OCCLUDING, VASCULAR, PERMANENT Back to Search Results
Model Number VS-402
Device Problems Device Difficult to Setup or Prepare (1487); Physical Resistance/Sticking (4012)
Patient Problem Blood Loss (2597)
Event Date 01/31/2020
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Physician intended to use a venaseal kit during treatment of the patient¿s great saphenous vein (gsv).Ifu was followed.The physician flushed the blue venaseal introducer and left the syringe attached.During the prep and priming of the venaseal delivery catheter the physician noted the blue venaseal introducer would not flush again.The elapsed time between when the blue introducer was flushed to when it would not flush was about 1-2 minutes.The primed delivery catheter was inserted into the blue venaseal introducer with noted resistance.A clot was identified in the shape of the blue introducer along the proximal gsv through the saphenofemoral junction (sfj) into the common femoral vein.The venaseal delivery catheter with the attached blue introducer were removed from the patient.The 7 fr.Sheath was removed from the patient.Pressure was held to achieve haemostasis.A dry sterile dressing was applied.When the patient started to walk around the bleeding continued, pressure was applied, and haemostasis was achieved again.The initial dressing was saturated with blood and replaced with another dry sterile dressing.The procedure was aborted, and the physician prescribed eliquis to the patient for a 7-day course.The patient is scheduled to return for follow up next week.It will be determined at follow up if the clot has resolved to reschedule the patient for the venaseal procedure.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Product analysis: the venaseal device was returned within a saftpak biohazard pouch and within a clear biohazard bag.Blood residue was observed on all the returned components.The catheter tip was occluded with dried adhesive.Blood residue was observed on the entire catheter shaft.No physical damage was noted on the catheter.The blue introducer was occluded with blood residue within its lumen.Due to the occlusion of the introducer, a known good catheter from analysis lab cannot be inserted within the introducer.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: the procedure was aborted during an attempt to treat the left great saphenous vein (gsv) with venaseal.No adhesive was administered to the patient.Patient had a follow up consultation approximately 4 weeks after the procedure.There is no ultrasound evidence of the suspicious area of the clot.The gsv in the left lower extremity of the leg has occluded, but the upper vessel remains incompetent and open.No presence of edema.There is still some heaviness in the left leg, but this is not debilitating.There is no walking related complaints compatible with claudication.Patient is in good health with no major medical or surgical problems.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VENA SEAL CLOSURE SYSTEM
Type of Device
AGENT, OCCLUDING, VASCULAR, PERMANENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9659116
MDR Text Key177539687
Report Number9612164-2020-00520
Device Sequence Number1
Product Code PJQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140018
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 03/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/30/2021
Device Model NumberVS-402
Device Catalogue NumberVS-402
Device Lot Number57181
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/28/2020
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/31/2020
Initial Date FDA Received02/03/2020
Supplement Dates Manufacturer Received02/24/2020
03/10/2020
03/17/2020
Supplement Dates FDA Received02/26/2020
03/12/2020
03/19/2020
Date Device Manufactured09/25/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age66 YR
Patient Weight100
-
-